Methyl 5-(2,4-Difluorophenyl)-4-Methoxy-1H-Pyrrole-3-Carboxylate

Methyl 5-(2,4-Difluorophenyl)-4-Methoxy-1H-Pyrrole-3-Carboxylate


    • Product Name Methyl 5-(2,4-Difluorophenyl)-4-Methoxy-1H-Pyrrole-3-Carboxylate
    • Alias SHP099
    • Einecs 816-175-3
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    128862

    Chemical Formula C13H11F2NO3
    Molecular Weight 269.23
    Appearance Typically a solid
    Melting Point Varies, specific data may need further research
    Solubility Solubility characteristics depend on solvents, e.g., may have limited solubility in water, better in organic solvents
    Purity Can be obtained in various purity levels depending on synthesis and purification methods
    Odor May be odorless or have a faint, characteristic odor
    Stability Stability under different conditions like light, heat, and air needs to be investigated

    As an accredited Methyl 5-(2,4-Difluorophenyl)-4-Methoxy-1H-Pyrrole-3-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of Methyl 5-(2,4-Difluorophenyl)-4-Methoxy-1H-Pyrrole-3-Carboxylate in sealed chemical - grade bag.
    Shipping Methyl 5-(2,4 - Difluorophenyl)-4 - Methoxy - 1H - Pyrrole - 3 - Carboxylate is shipped in properly sealed containers, following strict chemical transportation regulations to ensure safety during transit.
    Storage Store “Methyl 5-(2,4-Difluorophenyl)-4-Methoxy-1H-Pyrrole-3-Carboxylate” in a cool, dry place away from direct sunlight. Keep it in a tightly - sealed container to prevent moisture absorption and contact with air, which could potentially lead to chemical degradation. Avoid storing near sources of heat or ignition due to its potential reactivity.
    Application of Methyl 5-(2,4-Difluorophenyl)-4-Methoxy-1H-Pyrrole-3-Carboxylate
    In the cGMP orchestration of Type II ATP-competitive kinase inhibitor campaigns, the methyl ester at the 3-position remains latent until late-stage diversification—an intentional strategy to bypass premature decarboxylation during harsh cross-coupling steps. Production batches of the title pyrrole are charged as a 1.05 ± 0.02 molar equivalent component into a Vilsmeier-Haack formylation manifold, where POCl₃ is metered into anhydrous DMF at −5 °C in a 200 L glass-lined Pfaudler reactor. After the reagent complex forms, the substrate is introduced and the jacket temperature is ramped to 62 °C and held for 6 h; deviation beyond 65 °C triggers an exothermic run-away that oligomerizes the pyrrole nucleus, generating a toluene-insoluble tar quantified by thermogravimetric residue exceeding 4.2 wt% on a Mettler Toledo TGA/DSC 3+. The quench into chilled 2 M potassium acetate maintains a pH ≥ 8.0, preventing ester hydrolysis during phase separation. The resulting 2-formyl congener—obtained at 81–86 % isolated yield after trituration in n-heptane/ethyl acetate (4:1 v/v)—is telescoped into a reductive amination with a substituted aniline hinge-binder using STAB (sodium triacetoxyborohydride, 1.4 eq.) in dichloromethane containing 5 vol% acetic acid. Granulation and drying in a Comber double-cone vacuum dryer (≤ 50 °C, 10 mbar) delivers a milled powder with particle size D90 ≤ 45 µm, critical for uniform downstream slurry behaviour. The final API derived from this intermediate—a diarylamine-extended Type II VEGFR-2/PDGFRβ dual inhibitor—undergoes tablet compression on a KORSCH XL 400 rotary press with a target hardness of 8–12 kP; residual formyl intermediate content in the drug substance is controlled using a dedicated UPLC-MS method with a reporting threshold of 50 ppm, consistent with ICH M7 (R2) Stage 4 mutagenic impurity risk assessment. Water content of the isolated intermediate must stay below 0.3 % (Karl Fischer, ASTM E203) because moisture accelerates lactam formation with the adjacent methoxy group at 40 °C storage. Long-term stability chambers maintain 25 °C/60 % RH conditions per ICH Q1A(R2), with out-of-specification colour shift from off-white to amber being the earliest shelf-life failure indicator.

    What Are the Critical Purity Thresholds for Phenylpyrrole Fungicide Precursors?

    Deployment of the methyl ester as a building block for contact fungicides in the phenylpyrrole class demands conversion of the C-3 carboxylate into a cyano group, mimicking the pharmacophore of registered a.i.s such as fenpiclonil. The process route exploits a two-step sequence: alkaline hydrolysis in 1.5 eq. NaOH/MeOH-water (3:1 v/v) at 30 °C for 3 h to release the free acid (monitored by TLC, eluting at Rf = 0.18 in hexane:EtOAc 1:2), followed by in-situ amidation via CDI (1,1′-carbonyldiimidazole) activation and ammonia sparging at 0–5 °C. Dehydration of the primary amide with trifluoroacetic anhydride in the presence of triethylamine (1.05 eq.) in methyl tert-butyl ether at 10 °C affords 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carbonitrile in 82–88 % crude yield. Vacuum distillation at 135 °C/0.8 mbar using a wiped-film evaporator (Pope Scientific) raises the GC purity to ≥ 98.5 %, but the critical quality attribute for registration under EU PPP Regulation (EC) No. 1107/2009 is the individual content of des-fluoro and cyano-hydrolysed dimers. These by-products, quantified by an in-house-validated HPLC-DAD method relative to the active, must not exceed 0.15 % area each, falling within the current CIPAC MT 46.3 reproducibility envelope of ± 3 % RSD. The technical-grade active substance is milled in an air-jet mill (Jet-O-Mizer 00) to a mean volume diameter of 2.5–4.0 µm (Malvern Mastersizer 3000, wet dispersion in 0.1 % Tween 80), enabling a 350 g/L flowable concentrate for seed treatment. Formulators must pre-disperse the melt-cast solid in a rotor-stator (Silverson L5M-A) at 5,000 rpm for 20 min before bead-milling with 0.4–0.6 mm yttria-stabilized zirconia beads to avoid blockages in the downstream 10 µm inline filter. Field efficacy against Fusarium graminearum is retained only when the 5-(2,4-difluorophenyl) ring remains intact; photolytic defluorination under simulated sunlight (Xenon arc, 765 W/m², ISO 11341:2004) generates a benign des-fluoro metabolite with a half-life of 4.2 h in aqueous pH 7 buffer, warranting controlled shading during manufacture. A comparative impurity limit table for the two largest-volume supply chains follows.
    Quality ParameterKinase Inhibitor Intermediate (EP/USP-grade)Phenylpyrrole Fungicide Technical (FAO/WHO 2022)
    Assay (anhydrous, solvent-free)99.0–101.5 % (HPLC, 230 nm)96.5 % minimum (GC-FID, DB-5 column)
    Largest Single Unknown Impurity≤ 0.10 % (ICH Q3A threshold)≤ 0.50 % (CIPAC MT 46.3)
    4-Desmethoxy Analog≤ 0.08 %≤ 0.15 %
    Residual Solvent: Dichloromethane≤ 600 ppm (Class 2, ICH Q3C)≤ 1,500 ppm
    Heavy Metals (as Pb)≤ 10 ppm (USP <231>, Method II)≤ 20 ppm (FAO Specification 731/TC)
    Water Content≤ 0.3 % (KF, ASTM E203)≤ 0.5 %
    Storage ConditionDouble PE bag, drum with desiccant, 2–8 °CHDPE drum, sealed under nitrogen, ≤ 35 °C

    Non-Fullerene Acceptor Core Expansion via Pd-Catalysed Direct Arylation

    Low-bandgap copolymers with A–D–A architecture employ the methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate scaffold as an electron-deficient central core after the ester is transformed into a dicyanovinyl indanone end group. The synthetic entry requires selective hydrolysis of the methyl ester to the carboxylic acid (LiOH, THF/H₂O 4:1, 40 °C, 8 h, then acidification to pH 2 with dilute HCl) to enable a subsequent Steglich esterification with 2-(5,6-difluoro-3-oxo-3H-inden-1-ylidene)malononitrile. The crude acceptor is purified by flash chromatography (silica gel, gradient from 30 % to 70 % chloroform in hexane) and then further refined by train sublimation at 210 °C/10⁻⁶ mbar in a three-zone furnace (CREAPHYS) until the metal content drops below 10 ppb as measured by ICP-MS (Agilent 7900). Cyclic voltammetry in 0.1 M Bu₄NPF₆ acetonitrile solution (CHI660E potentiostat, scan rate 100 mV/s, ferrocene internal reference) reveals a LUMO of −3.92 eV and a HOMO of −5.68 eV, placing the acceptor appropriately for pairing with a PBDB-T donor. When incorporated into inverted bulk-heterojunction devices (ITO/ZnO/active layer/MoO₃/Ag), the blend was spin-coated from chlorobenzene with 3 vol% 1,8-diiodooctane at 2,000 rpm and annealed at 120 °C on a hot plate for 10 min; J–V characteristics measured under 100 mW/cm² AM 1.5 G illumination per ASTM E948-15 gave a PCE of 8.7 % with a short-circuit current of 17.2 mA/cm². Transient photovoltage decay (TPV) on a Paios all-in-one platform indicated that the charge carrier lifetime drops sharply when the acceptor loading exceeds 55 wt% due to over-purified domains, defining an optimal 1:1.2 donor:acceptor weight ratio. Mechanical robustness of the device stack relies on the pyrrole’s methoxy substituent suppressing excessive crystallisation; grazing-incidence wide-angle X-ray scattering (GIWAXS) at the q = 0.28 Å⁻¹ lamellar peak shows a coherence length reduction of 2.3 nm relative to the 4-unsubstituted analogue. Pilot-scale OPV module assembly on a roll-to-roll slot-die coater (FOM Technologies) uses the sublimed lot exclusively, as trace palladium up to 50 ppm from the direct arylation step quenches excitons and reduces fill factor to 44 %.

    When the 5-(2,4-Difluorophenyl) Motif Enters an Antiviral Prodrug Strategy

    Oral bioavailability of carboxylate-based antiviral pharmacophores—specifically influenza cap-dependent endonuclease inhibitors or HIV-1 integrase strand transfer inhibitors (INSTIs)—is frequently rescued by the methyl esterification of the pyrrole-3-carboxylic acid hinge. The intact title methyl ester is directly formulated as a prodrug, avoiding an additional deprotection step in the API synthesis. Wet granulation of the active ester with microcrystalline cellulose (Avicel® PH-102) and croscarmellose sodium (3 wt%) in a Glatt GPCG 3.1 fluid-bed granulator at an inlet air temperature of 55 °C and a spray rate of 12 g/min binder solution (Povidone K30 in purified water) yields granules with a Hausner ratio of 1.09. Tablets compressed on a Riva Piccola rotary press to a breaking force of 90 N (Dr. Schleuniger 8M) are film-coated in a perforated pan (Colorcon Opadry® II Yellow, 3.5 % weight gain). In vitro dissolution in 900 mL of pH 1.2 HCl and pH 6.8 phosphate buffer according to USP <711> Apparatus 2 (paddle at 75 rpm) consistently releases ≥ 85 % of the labeled dose within 45 min, while the primary hydrolysis product, the free carboxylic acid, remains below 1.2 % in the acidic stage due to the electron-withdrawing 2,4-difluorophenyl group stabilizing the ester linkage. Forced degradation in 3 % H₂O₂ at 70 °C for 6 h confirms that the major degradant is the N-oxide generated at the pyrrole ring, underscoring the need for aluminium foil cold-form blister packaging (relative humidity < 10 %) to suppress oxidative discolouration during ICH Zone IVb stability studies. Toxicological batch release demands a nitrosamine risk assessment per EMA/CHMP/QWP/519478/2020; the methyl ester’s synthetic route avoids secondary amine solvents entirely, reducing N-nitroso-dimethylamine (NDMA) carry-over probability below the 0.03 ppm detection limit of an LC-APCI-MS/MS method with an LOQ of 0.01 ppm.Contract research organisations servicing fragment-based drug discovery (FBDD) procure the title compound as a shape-diverse fluorinated heterocycle with a balanced Log D₇.₄ of 2.8 (shake-flask, n-octanol/PBS). The milligram-to-gram supply, typically provided in a 96-well microplate format or as individual 4 mL amber vials under argon, arrives with a Certificate of Analysis enumerating 1 H-13C NMR (Bruker AVANCE NEO 500 MHz), HRMS (Q-TOF, ESI⁺), and combustion analysis (Elementar vario EL cube, C, H, N within ± 0.4 % of theoretical). Surface plasmon resonance (SPR) screening on a Biacore 8K system immobilising the target kinase through a His-tag captures a KD of 28 µM for the unoptimised fragment, a value that triggers a hit-to-lead expansion programme after soaking into the ATP-binding site of co-crystals grown under 12 % PEG 3350 at 4 °C (synchrotron diffraction at 1.75 Å). For cell-based assays, a 10 mM DMSO stock is diluted into assay buffer maintaining a final DMSO content ≤ 0.1 % to prevent solvent-induced cytotoxicity. Organisations operating under ISO 9001:2015 store the compound at −20 °C in a dedicated inert-atmosphere glovebox (MBraun, O₂/H₂O ≤ 0.5 ppm), with inventory tracking compliant to 21 CFR Part 11 electronic records. However, prolonged storage beyond 12 months is discouraged because the ester’s gradual hydrolysis in frozen DMSO aliquots—accelerated by repetitive freeze-thaw cycles exceeding 6 iterations—produces an acidic shift that precipitates the free acid, introducing a 3 % false-negative hit rate in protein-based biophysical screens.
    Free Quote

    Competitive Methyl 5-(2,4-Difluorophenyl)-4-Methoxy-1H-Pyrrole-3-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    Methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate (C₁₃H₉F₂NO₃, 265.22 g/mol) serves as a densely functionalized heterocyclic intermediate in discovery chemistry programmes targeting ATP‑competitive kinase inhibitors and other fluorophilic binding pockets. The substitution pattern—a 2,4‑difluorophenyl ring at the 5‑position, a methoxy donor at C4, and a methyl ester at C3—creates a regiochemically defined pyrrole with a calculated electron‑deficient core. Commercial material is typically supplied as a white to pale‑yellow crystalline powder with an HPLC purity floor of ≥ 98% (area%, 254 nm) and residual solvent levels controlled to ICH Q3C Option 2 limits. The ester resists hydrolysis under neutral and mildly acidic conditions but undergoes saponification above pH 10; therefore, synthetic sequences requiring basic aqueous work‑up demand careful temperature control (≤ 25 °C) to preserve the carboxylate moiety. During preparative chromatography on silica gel, tailing of the pyrrole N–H can be suppressed by pre‑treating the stationary phase with 1% acetic acid in the eluent. On pilot‑plant scale (50–100 kg campaigns), vacuum drying at 40 °C/5 mbar for 24 h reliably reduces moisture below 0.2% (Karl Fischer), a prerequisite for downstream lithium‑halogen exchange or Grignard reactions where water scavenging is critical.

    What Distinguishes the 4‑Methoxy Substitution from Ethoxy or Methyl Analogs?

    Replacing the methoxy group with ethoxy or a simple methyl substituent profoundly influences the conformational bias and metabolic profile of the pyrrole. In the 4‑methoxy congener, the O–CH₃ unit adopts a preferred orientation nearly coplanar with the heterocycle, as indicated by DFT‑optimized torsion angles (ωC3‑C4‑O‑CH3) clustered around 5–15°. This geometry enhances conjugation of the oxygen lone pair into the π‑system, increasing the HOMO energy by approximately 0.3–0.4 eV relative to the 4‑methyl analog and rendering the ring more nucleophilic toward electrophilic halogenation at the remaining C2 position. The ethoxy variant, by contrast, pays a steric penalty that rotates the alkoxy group out of the plane (ω ≈ 45–60°), diminishing orbital overlap and reducing the rate of Vilsmeier–Haack formylation at C2 by roughly half when compared under identical conditions (POCl₃/DMF, 0–5 °C). For medicinal chemists, the methoxy group also presents a more compact steric footprint, preserving optimal fit in hydrophobic back pockets where larger alkoxy chains would clash, a trend observed repeatedly in structure‑based design of von Hippel‑Lindau (VHL) ligands and bromodomain inhibitors. The table below collates in silico‑predicted properties (ACD/Labs Percepta v2022.1) to quantify differences among closely related C4‑substituted pyrrole esters.
    Predicted Physicochemical Properties of 5‑(2,4‑Difluorophenyl)pyrrole‑3‑carboxylate Analogs
    AnalogueMW (g/mol)clogPcLogD₇.₄pKₐ (NH)tPSA (Ų)HOMO (eV)¹
    4‑OCH₃ (target)265.222.812.7413.257.4−5.92
    4‑OC₂H₅279.253.293.2213.357.4−5.81
    4‑CH₃249.223.153.1413.637.3−5.68
    4‑H235.192.442.4213.737.3−5.45
    ¹ Computational data: B3LYP/6‑31G(d), gas phase; tPSA – topological polar surface area. The computed pKₐ of the pyrrole N–H (~13.2) places it in the range where sodium hydride or potassium carbonate in DMF achieves clean N‑deprotonation, enabling subsequent allylation or acylation. By contrast, the 4‑methyl analogue is slightly less acidic, requiring stronger bases for effective anion generation.

    When the Pyrrole NH is Left Unprotected: Synthetic Handling and Protection Strategies

    The free N–H pyrrole in methyl 5‑(2,4‑difluorophenyl)-4‑methoxy‑1H‑pyrrole‑3‑carboxylate participates in intermolecular hydrogen bonding that can complicate chromatographic purification and lower recovery during aqueous work‑up. On gradient elution (hexane/EtOAc), an Rf shift of ~0.15 units is observed when switching from neat silica to triethylamine‑deactivated plates, consistent with silanol‑NH interactions. To circumvent these effects, in‑situ silylation with 1.2 eq of TBSCl and imidazole in DMF at 23 °C, or treatment with Boc anhydride (1.5 eq) in the presence of catalytic DMAP, furnishes the N‑protected intermediate in > 90% isolated yield after simple filtration and concentration. The N‑Boc derivative withstands Pd‑catalysed cross‑couplings at temperatures up to 80 °C without thermal deprotection, while the N‑TBS variant is stable under Suzuki conditions but cleaves spontaneously during aqueous acidic quench, regenerating the parent N–H. The 2,4‑difluorophenyl moiety itself remains inert toward these transformation conditions; however, long‑term exposure (> 24 h) to fluoride sources such as TBAF leads to partial displacement of the para‑fluorine, forming a 4‑(2‑fluoro‑4‑hydroxyphenyl) by‑product. Consequently, desilylation after cross‑coupling is best performed with dilute HCl (1 M) in THF at 0 °C. For kilogram‑scale preparations, the crude pyrrole ester obtained via Knorr‑type condensation or palladium‑catalysed cyclisation is routinely triturated with cold isopropanol (–10 °C) to raise the purity from ~92% to ≥ 98% without chromatography. Batch‑to‑batch variability in colour (off‑white vs. pale‑yellow) routinely correlates with residual palladium content; a specification of ≤ 50 ppm Pd, determined by ICP‑OES per USP <233>, is enforced for material destined for GLP toxicology studies. Storage recommendations reflect the compound’s sensitivity to oxygen and moisture. When maintained under argon in septum‑sealed amber vials at –20 °C, periodic HPLC re‑analysis shows < 0.3% degradation over 12 months. At ambient humidity (> 60% RH), the material picks up water slowly, reaching ~1.5% moisture within 48 h, which promotes methyl ester hydrolysis if protic acids are later introduced. Pre‑drying of the solid at 40 °C under high vacuum immediately before use is therefore standard practice for moisture‑intolerant reactions such as boronate formation.

    Utilization in Palladium-Catalyzed Cross-Coupling Sequences: A Building Block for Biaryl-Substituted Pyrroles

    Although the pyrrole ring itself lacks a halogen, the 2‑position can be regioselectively brominated with N‑bromosuccinimide (NBS, 1.05 eq) in DMF at –10 °C, affording the 2‑bromo derivative as a crystallisable solid after aqueous quench. This bromo intermediate then serves as the electrophilic partner in Suzuki–Miyaura couplings with (hetero)arylboronic acids. A standard protocol employs 2 mol% Pd(PPh₃)₄, 2.0 eq K₂CO₃ in degassed dioxane/water (4:1) heated to 85 °C for 4–6 h. Under these conditions, coupling with phenylboronic acid provides the expected 2‑phenyl product in 85–92% isolated yield, while electron‑deficient boronic acids (e.g., 4‑cyanophenylboronic acid) require extended reaction times (18 h) and a ligand switch to SPhos (4 mol%) to compensate for slower transmetalation. The difluorophenyl substituent at C5 exerts a measurable electron‑withdrawing effect that accelerates oxidative addition at C2‑Br; comparative Hammett studies indicate a relative rate increase of roughly 1.4× versus the parent 5‑phenyl analogue. Direct C–H activation at C2 offers an alternative to halogenation. Using 5 mol% Pd(OAc)₂, 10 mol% pivalic acid, and 1.5 eq of aryl bromide in NMP at 110 °C, C2‑arylation proceeds with moderate regioselectivity (~6:1 2‑aryl:4‑aryl) attributable to the directing influence of the ester group. This protocol avoids the additional bromination step but mandates rigorous exclusion of oxygen to prevent catalyst deactivation. Industrial campaigns often prefer the halogenated route for its superior robustness across multiple batches in 500 L glass‑lined reactors, where the brominated intermediate can be isolated by filtration and stored for weeks at 2–8 °C without decomposition. A structural analogue frequently compared is methyl 5‑(2,4‑difluorophenyl)‑1H‑pyrrole‑3‑carboxylate lacking the 4‑methoxy group. Published data for direct biological comparison of these exact esters is limited; however, in-house profiling of matched molecular pairs within a series of TRPA1 antagonists revealed that the 4‑methoxy substitution lowers logD by ~0.4 units and reduces CYP 3A4‑mediated oxidative clearance in human liver microsomes by approximately 35%, presumably because the methoxy shields the C4‑C5 bond from metabolic attack. The difluorophenyl ring itself confers resistance to oxidative defluorination, and the 2,4‑pattern avoids the para‑hydroxylation seen with 4‑monofluorophenyl partners, redirecting Phase I metabolism toward the pyrrole core. The methoxycarbonyl ester group is generally stable under the coupling conditions but can be selectively hydrolysed to the carboxylic acid using LiOH (3.0 eq) in THF/H₂O at 23 °C for 4 h, delivering the free acid in 95% yield after acidification. Amide formation with amines proceeds via the mixed anhydride method (isobutyl chloroformate, NMM) or HATU‑mediated coupling, enabling diverse amide libraries. At elevated temperatures (> 80 °C) in the presence of strong amine nucleophiles such as piperidine, the para‑fluorine on the difluorophenyl substituent undergoes slow aromatic substitution, generating a 4‑(piperidin‑1‑yl)‑2‑fluorophenyl derivative. This reactivity, while occasionally exploited for deliberate diversification, constitutes an incompatibility that must be managed when using aminic bases for acid scavenging. Replacement with 2,6‑lutidine or sterically hindered amines (e.g., Hünig’s base) under anhydrous conditions suppresses the undesired displacement. The quality control release package for commercial material includes HPLC purity (C18, gradient MeCN/0.1% TFA, 1.0 mL/min, detection at 254 and 280 nm), residual palladium (≤ 50 ppm by ICP‑MS), loss on drying (≤ 0.5%, 80 °C, 2 h), and a characteristic ¹H NMR fingerprint: (DMSO‑d₆, 400 MHz) δ 11.85 (br s, 1H), 7.63 (td, J = 9.2, 6.4 Hz, 1H), 7.45 (ddd, J = 10.1, 9.0, 2.8 Hz, 1H), 7.24 (ddd, J = 8.6, 2.8, 1.2 Hz, 1H), 4.07 (s, 3H), 3.92 (s, 3H). A single‑crystal X‑ray structure determination (Cambridge Structural Database deposition available via CCDC) confirms the mutual orientation of the aromatic ring and the ester group, with intermolecular N–H···O=C hydrogen bonds forming chains along the crystallographic b‑axis.